Assessment of novel inflammatory, clinical and radiologicalresponse (â??Brixiaâ?? chest X ray score) to remdesivir in moderate and severe COVID-19patients : a retrospective study

Vishal Shanbhag0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Patients aged 18-90 years were included
•Patients who have been proven COVID-19 positive by reverse transcriptase polymerase chain reaction (RT-PCR),and the rapid antigen test.
•COVID -19 patients admitted between June 2020 and September 2020
•Patients above 18 years admitted to hospital or critical care unit and on oxygen therapy, non-invasive ventilation (NIV) or invasive mechanical ventilation (IMV)

•Patients with pre-existing liver disorders.
•2. Patients with any prior hypoalbuminemic state.
•3. Patients with hematological malignancies, immunocompromised states.
•4. Patients with fluid resuscitations where the serum albumin level couldbe altered.
•5. patients with trauma,extensive bowel resection,burns
•6. Patients with AKI or CKD with possible albumin loss in urine

发起方

Vishal Shanbhag